Spread the love“`html If you’re a Java developer, you may have heard of IntelliJ IDEA, one of the most powerful Integrated Development Environments (IDEs) available today. But do you really know how ...

GPT-Live enables natural real-time conversations, but experts caution against mistaking convincing AI behavior for human ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

End-of-support is coming for four long-term support versions of Java, starting in 2029. Avoid the stress of parallel modernization projects and get started now. Between 2029 and 2032, every currently ...

OpenAI’s latest voice AI model, GPT Realtime 2, introduces advanced capabilities for natural and context-aware interactions. Built on the GPT-5-level reasoning framework, it handles complex tasks such ...

OpenAI has announced three new real-time voice and audio API models, giving developers more options for building live voice agents, translation tools, and speech-to-text apps. The new lineup includes ...

OpenAI has introduced three new audio models through its API, expanding its push into real-time voice AI for developers. The launch includes GPT-Realtime-2, GPT-Realtime-Translate, and ...

OpenAI explains in more detail what’s new with the GPT-5-class GPT-Realtime-2 voice model with reasoning: GPT‑Realtime‑2 is built for live voice interactions where the model keeps the conversation ...

May 7 (Reuters) - OpenAI introduced three audio models for its developer platform on Thursday, aiming to make voice-based software agents more ‌conversational and capable of completing tasks in real ...

Through a new pilot program announced this week, the Food and Drug Administration will use artificial intelligence and cloud computing to monitor clinical trial data in real time, an effort that could ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.